Wet Chemicals for TFT-LCD OLED Panel Market
Wet chemicals, also known as ultra-clean high-purity reagents or process chemicals, refer to chem ... Read More
Programmed death-ligand 1 also known as cluster of differentiation 274 or B7 homolog 1 is a protein that in humans is encoded by the CD274 gene.
This report contains market size and forecasts of PD-L1 and PIK3CA Testing Product in global, including the following market information:
Global PD-L1 and PIK3CA Testing Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PD-L1 and PIK3CA Testing Product Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five PD-L1 and PIK3CA Testing Product companies in 2021 (%)
The global PD-L1 and PIK3CA Testing Product market was valued at 536.9 million in 2021 and is projected to reach US$ 1849 million by 2028, at a CAGR of 19.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-L1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-L1 and PIK3CA Testing Product include Agilent Technologies, Roche, QIAGEN, EntroGen, Foundation Medicine, Amoy Diagnostics and ACCB Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 and PIK3CA Testing Product manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-L1 and PIK3CA Testing Product Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD-L1 and PIK3CA Testing Product Market Segment Percentages, by Type, 2021 (%)
PD-L1
PIK3CA
Global PD-L1 and PIK3CA Testing Product Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD-L1 and PIK3CA Testing Product Market Segment Percentages, by Application, 2021 (%)
Hospital
Diagnostic Center
Others
Global PD-L1 and PIK3CA Testing Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD-L1 and PIK3CA Testing Product Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD-L1 and PIK3CA Testing Product revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PD-L1 and PIK3CA Testing Product revenues share in global market, 2021 (%)
Key companies PD-L1 and PIK3CA Testing Product sales in global market, 2017-2022 (Estimated), (K Units)
Key companies PD-L1 and PIK3CA Testing Product sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
Roche
QIAGEN
EntroGen
Foundation Medicine
Amoy Diagnostics
ACCB Biotech
Wet chemicals, also known as ultra-clean high-purity reagents or process chemicals, refer to chem ... Read More
Ceramic additive manufacturing (C-AM) is highlighted as a technology that can overcome the inher ... Read More
A bone anchored hearing aids is a surgically implanted device designed to help people with partic ... Read More
In vitro diagnostics offer the opportunity to detect cancer early, for more effective and time ... Read More